Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Birkenfeld AL, Schroeder C, Boschmann M, Tank J, Franke G, Luft FC, Biaggioni I, Sharma AM, Jordan J (2002) Circulation 106: 2459-65 RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals. Chen KY, Muniyappa R, Abel BS, Mullins KP, Staker P, Brychta RJ, Zhao X, Ring M, Psota TL, Cone RD, Panaro BL, Gottesdiener KM, Van der Ploeg LH, Reitman ML, Skarulis MC (2015) J Clin Endocrinol Metab 100: 1639-45 Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, Aronne L, NN8022-1923 Investigators (2013) Int J Obes (Lond) 37: 1443-51 Metabolic responses to exogenous ghrelin in obesity and early after Roux-en-Y gastric bypass in humans. Tamboli RA, Antoun J, Sidani RM, Clements A, Harmata EE, Marks-Shulman P, Gaylinn BD, Williams B, Clements RH, Albaugh VL, Abumrad NN (2017) Diabetes Obes Metab 19: 1267-1275 Lichenoid eruption associated with orlistat. Sergeant A, Milne G, Shaffrali F (2006) Br J Dermatol 154: 1020-1 Molecule of the month. The 'skinny' on CB1 antagonists/inverse agonists: controversial obesity drugs will not go to FDA for approval. Lindsley CW (2008) Curr Top Med Chem 8: 1553 Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment. Dosoky NS, Chen Z, Guo Y, McMillan C, Flynn CR, Davies SS (2019) Appl Microbiol Biotechnol 103: 6711-6723 Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity. Moore MC (2006) Curr Opin Investig Drugs 7: 924-35 What are the risks and the benefits of current and emerging weight-loss medications? Robinson JR, Niswender KD (2009) Curr Diab Rep 9: 368-75 Oleoylethanolamide: A fat ally in the fight against obesity. Brown JD, Karimian Azari E, Ayala JE (2017) Physiol Behav 176: 50-58 Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice. Lee EY, Kim YW, Oh H, Choi CS, Ahn JH, Lee BW, Kang ES, Cha BS, Lee HC (2014) Metabolism 63: 793-9 Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues. Mäde V, Bellmann-Sickert K, Kaiser A, Meiler J, Beck-Sickinger AG (2014) ChemMedChem 9: 2463-74
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.